Genetika+ is developing a personalized medical testing tool to better treat depression by helping physicians find the best drug therapy for their patients. The Genetika+ test uses innovative technology to predict the best drug treatment for each patient, enabling faster treatment, fewer side effects, and lower dosing.
FUND I / ACTIVE
Genetika+ is a screening platform that helps physicians find the right medication to treat patients that suffer from major depression. Using biomarkers, patient history and genetics, Genetika+ screens the individualized efficacy of the 70+ antidepressants that are currently on the market.